Your browser doesn't support javascript.
loading
Weight loss and outcomes in subjects with progressive pulmonary fibrosis: data from the INBUILD trial.
Kreuter, Michael; Bendstrup, Elisabeth; Jouneau, Stéphane; Maher, Toby M; Inoue, Yoshikazu; Miede, Corinna; Lievens, Dirk; Crestani, Bruno.
Affiliation
  • Kreuter M; Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Care Medicine, Thoraxklinik, University of Heidelberg, and German Center for Lung Research, Heidelberg, Germany. kreuter@uni-heidelberg.de.
  • Bendstrup E; Center for Pulmonary Medicine, Departments of Pneumology, Mainz University Medical Center and of Pulmonary, Critical Care & Sleep Medicine, Marienhaus Clinic Mainz, Mainz, Germany. kreuter@uni-heidelberg.de.
  • Jouneau S; Department of Respiratory Diseases and Allergy, Centre for Rare Lung Diseases, Aarhus University Hospital, Aarhus, Denmark.
  • Maher TM; Department of Respiratory Medicine, Competences Centre for Rare Pulmonary Diseases, CHU Rennes, University of Rennes, Rennes, France.
  • Inoue Y; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Miede C; Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai City, Osaka, Japan.
  • Lievens D; mainanalytics GmbH, Sulzbach (Taunus), Germany.
  • Crestani B; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Respir Res ; 24(1): 71, 2023 Mar 09.
Article in En | MEDLINE | ID: mdl-36894966
Patients with worsening fibrosis (scarring) of the lungs may lose weight. This study suggests that the course of disease may be worse in patients who lose weight. Measures to prevent weight loss may be needed in these patients.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Idiopathic Pulmonary Fibrosis Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Respir Res Year: 2023 Type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Idiopathic Pulmonary Fibrosis Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Respir Res Year: 2023 Type: Article Affiliation country: Germany